The natural β-carbolines facilitate inositol phosphate accumulation by activating small G-proteins in human neuroblastoma cells (SH-SY5Y)

Neuropharmacology

Volumn 36, Issue 11-12, 1997, Pages 1771-1778

  Lichtenberg Kraag, B ^a   Klinker, J F ^a   Muhlbauer E ^a   Rommelspacher, H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

carboline; Carbachol; Phosphatidylinositol phosphates; Phospholipase C; SH SY5Y neuroblastoma cells; Small GTP binding proteins

Indexed keywords

BETA CARBOLINE; BETA CARBOLINE DERIVATIVE; BRADYKININ; CARBACHOL; DIAZEPAM; ETONITAZENE; GLUTAMATE RECEPTOR AGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN; HARMAN; INOSITOL PHOSPHATE; MORPHINE; MUSCARINIC AGENT; OPIATE; PHOSPHOLIPASE C; TYRAMINE;

ARTICLE; BINDING SITE; DRUG EFFECT; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BINDING SITES; BIOTRANSFORMATION; BOTULINUM TOXINS; BRAIN NEOPLASMS; CARBOLINES; GTP-BINDING PROTEINS; HUMANS; INOSITOL PHOSPHATES; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0031406041     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00167-6     Document Type: Article

References (36)

1. Adell A. and Myers R. D. (1994) Increased alcohol intake in low alcohol drinking rats after chronic infusion of the β-carbolinium harman into the hippocampus. Pharmacology, Biochemistry and Behavior 49: 949-953.
2. Airaksinen M. M., Lecklin A., Saano V., Tuomisto L. and Gynther J. (1987) Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by β-carbolines. Pharmacology and Toxicology 60: 5-8.
3. Brossi, A. (1993) Mammalian alkaloids II. In The Alkaloids, Vol. 43, pp. 119-183. Academic Press, New York.
4. Cappendijk S. L. T., Fekkes D. and Dzoljic M. R. (1994) The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine. Behavioural Brain Research 65: 117-119.
5. Chong L. D., Traynor-Kaplan A., Bobock G. M. and Schwartz M. A. (1994) The small GTP-binding protein Rho regulates a phosphatitylinositol 4-phosphate 5-kinase in mammalian cells. Cell 79: 507-513.
6. Cirrarone V., Spengler B. A., Meyers M. B., Biedler J. L. and Ross R. A. (1989) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Research 49: 219-225.
7. Ergene E. and Schoener E. P. (1993) Effects of harman (1-methyl-β-carboline) on neurons in the nucleus accumbens of the rat. Pharmacology, Biochemistry and Behavior 44: 951-957.
8. Fekkes D. and Bode W. T. (1993) Occurrence and partition of the β-carboline norharman in rat organs. Life Sciences 52: 2045-2054.
9. 2+ requirements for phospholipase C activation. Molecular Pharmacology 35: 195-204.
10. Fisher S. K., Slowiejko D. M. and McEwen E. L. (1994) A rapid attenuation of muscarinic agonist stimulated phosphoinositide hydrolysis precedes receptor sequestration in human SH-SY5Y neuroblastoma cells. Neurochemical Research 19: 549-554.
11. Jenkins G. H., Fisette P. L. and Anderson R. A. (1994) Type I phosphatidylinositol 4-phosphate 5-kinase isoforms are specifically stimulated by phosphatidic acid. Journal of Biological Chemistry 269: 11547-11554.
12. 2+ and inositol 1,4,5-trisphosphate mass in a human neuroblastoma cell line, SH-SY5Y. Biochemical Journal 265: 555-562.
13. kB transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis. Journal of Neuroscience 16: 5914-5922.
14. Machesky L. M. and Hall A. (1996) Rho: a connection between membrane receptor signalling and the cytoskeleton. Trends in Cell Biology 6: 304-310.
15. Matsubara K., Collins M. A., Akane A., Ikebuchi L., Neafsey E. J., Kagawa M. and Shiono H. (1993) Potential bioactivated neurotoxicants, N-methylated β-carboliniumitions, are present in human brain. Brain Research 610: 90-96.
16. 3H]Harman binding experimental: a reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat. Journal of Neurochemistry 56: 490-499.
17. May T., Greube A., Strauss S., Heineke D., Lehmann J. and Rommelspacher H. (1994) Comparison of the in vitro binding characteristics of the β-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla. Naunyn-Schmiedeberg's Archives of Pharmacology 349: 308-317.
18. Müller W. E., Fehske K. J., Borbe H. D., Wollert U., Nanz C. and Rommelspacher H. (1981) On the neuropharmacology of harman and other β-carbolines. Pharmacology, Biochemistry and Behavior 14: 693-699.
19. Naranjo, C. (1979) Psychotropic properties of the harmalan alkaloids. In Ethnopharmacologic Search for Psychoactive Drugs, ed. D. H. Efron, B. Holmstedt and N. S. Kline, pp. 385-391. Raven Press, New York.
20. Nimit, Y., Schulze, I., Cashaw, J. L., Ruchirawat, S. and Davis, V. E. (1982) Neurotransmitter, opiate, and benzodiazepine receptor binding of tetrahydroisoquinolines and β-carbolines in brain membranes. In Beta-carbolines and Tetrahydroisoquinolines, ed. F. E. Bloom, J. Barchas, M. Sander and E. Usdin, pp. 311-320. Liss, New York.
21. 3H]β-carboline) in the rat brain. European Journal of Pharmacology 147: 163-171.
22. Peterson G. L. (1983) Determination of total protein. Methods in Enzymology 91: 95-119.
23. Pike M. C., Bruck M. E., Arndt C. and Lee C.-S. (1990) Chemoattractants stimulate phosphatidylinositol-4-phosphate kinase in human polymorphonuclear leukocytes. Journal of Biological Chemistry 261: 1866-1873.
24. ceRI-mediated activation of rat basophilic leukemia cells by Clostridium difficile toxin B (monoglucosyltransferase). Journal of Biological Chemistry 271: 7324-7329.
25. Rommelspacher H., Büchau C. and Weiss J. (1987) Harman induces preference for ethanol in rats: is the effect specific for ethanol? Pharmacology, Biochemistry and Behavior 26: 749-755.
26. Rommelspacher H., May T. and Susilo R. (1991) β-Carbolines and tetranydro-isoquinolines: detection and function in mammals. Planta Medico 57: S85-S92.
27. Rommelspacher H., Dufeu P. and Schmidt L. G. (1996) Harman and norharman in alcoholism: correlations with psychopathology and long-term changes. Alcoholism: Clinical and Experimental Research 20: 3-8.
28. Rosenthal H. E. (1967) A graphic method for the determination and presentation of binding parameters in a complex system. Analytical Biochemistry 20: 525-532.
29. Ross R. A., Spengler B. A., Domenech C., Porubein M., Rettig W. J. and Biedler J. L. (1995) Human neuroblastoma 1-type cells are malignant neural crest stem cells. Cell Growth Differentiation 6: 449-456.
30. Sällström Baum S., Hill R. and Rommelspacher H. (1995) Norharman-induced changes of extracellular concentrations of dopamine in the nucleus accumbens of rats. Life Sciences 56: 1715-1720.
31. Schmidt M., Bienek C., Rümenapp U., Zhang C., Lümmen G., Jakobs K. H., Just J., Aktories K., Moos M. and Eichel-Streiber C. (1996) A role for Rho in receptor-and G-protein-stimulated phospholipase C. Reduction in phosphatidylinositol-4,5-bisphosphate by Clostridium difficile toxin B. Naunyn Schmiedeberg's Archives of Pharmacology 345: 87-94.
32. Skup M., Oderfeld-Nowak B. and Rommelspacher H. (1983) In vitro studies on the effect of β-carbolines on the activities of acetylcholinesterase and choline acetyltransferase and on the muscarinic receptor binding of the rat brain. Journal of Neurochemistry 41: 62-68.
33. Stephens L., Jackson T. R. and Hawkins P. T. (1993) Activation of phosphatidylinositol 4,5-bisphosphate supply by agonists and non-hydrolysable GTP analogues. Biochemical Journal 296:481-488.
34. Strömbom J., Jokela R., Saano V. and Rolfsen W. (1992) Binding of strychnocarpine and related β-carbolines to brain receptors in vitro. European Journal of Pharmacology 214: 165-168.
35. Vejdélek Z. J., Trcka V. and Protiva M. (1961) Synthetic experiments in the group of hypotensive alkaloids. XXI. Chemistry of 1,2,3,4-tetrahydronorharman-l-carboxylic acid and derivatives. Journal of Medical Pharmacy and Chemistry 3: 427-440.
36. 2+ signalling in human neuroblastoma cells. British Journal of Pharmacology 114: 1133-1142.